DLCS for Predicting Neoadjuvant Chemotherapy Response

Clinical trial NCT05617469 · UNKNOWN

Trial details

NCT number: NCT05617469
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Gastric Cancer CT Images Deep Learning Neoadjuvant Chemotherapy Tumor Regression Grade

Start date: 2022-07-01
Primary completion: 2023-01-30
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.